| Predicted Trait | |
| Reported Trait | Basal cell carcinoma (MTAG) |
| Mapped Trait(s) | basal cell carcinoma (EFO_0004193) |
| Score Construction | |
| PGS Name | MTAGPRS |
| Development Method | |
| Name | Genome-wide significant SNPs |
| Parameters | p<1e-04 |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 462 |
| Effect Weight Type | log(OR) |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000429 |
| Citation (link to publication) | Seviiri M et al. Nat Commun (2022) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 307,684 individuals (100%) |
| PGS Evaluation | European: 100% 1 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST90137411 Europe PMC: 36496446 |
307,684 individuals | European | GERA, QSKIN, UKB, eMERGE |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM017069 | PSS010113| European Ancestry| 18,933 individuals |
PGP000429 | Seviiri M et al. Nat Commun (2022) |
Reported Trait: Keratinocyte cancers | OR: 1.66 [1.55, 1.79] | — | — | age, sex, 10 ancesty PCs | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS010113 | — | — | 18,933 individuals | — | European | — | CLSA | — |